PGR and triple-negative breast carcinoma: Approximately, 15–20% of all breast carcinomas are included in the subgroup of triple-negative breast cancer (TNBC) that are characterized by the lack of ERα, progesterone receptor (PR), and EGFR 2 (Her-2) (64).